Biotech diligence on-demand

Rapid and rigorous technical and business diligence. Invest with confidence and win deals.

Trusted by leading investors

We have worked with clients ranging from angel syndicates to large venture funds and family offices, and check sizes from $200K to $10M+.

Whether you want a full outsourced diligence team including IP attorneys, scientists with decades of industry experience and leading academics, or if you just have a one-off question on a specific technology, we can help.

Expertise across all areas of biotech

We have extensive experience in the science and business of biotech. We've invested in, worked with or founded companies in the therapeutics, diagnostics, device and digital health sectors.

We offer our clients access to a large network of technical experts with expertise in medicinal chemistry, drug discovery, gene editing, synthetic biology, gene and cell therapy, cancer biology, protein engineering, neuroscience, artificial intelligence and machine learning, immunology, intellectual property, and many more.

Flexible solutions tailored to your process

Whether you want a full diligence process for a $15M investment -- including detailed technical diligence, IP evaluation, and qualitative and quantitative market research -- or just have a quick question on how well a new gene editing technique works, we have you covered. Get the benefits of a full diligence team without having to hire or manage anyone.

Rapid turnaround time

Moving quickly is a must in a competitive investing environment. But that doesn't mean you need to invest without fully evaluating the risks. We turn around initial reviews in days, and can complete full stack diligence including KOL and SME calls, IP diligence and literature reviews in 2 weeks. And our team is always available to you on Slack or email to answer one-off questions or connect you with experts.


Set up an intro call






Privacy policy

Terms of use

© 2019 Bay Bridge Bio, LLC